Highnoon Laboratories Limited (PSX:HINOON)

Pakistan flag Pakistan · Delayed Price · Currency is PKR
1,034.01
+7.13 (0.69%)
At close: Feb 13, 2026
Market Cap54.79B +17.5%
Revenue (ttm)26.61B +15.6%
Net Income3.67B +21.7%
EPS69.33 +21.7%
Shares Out52.98M
PE Ratio14.91
Forward PEn/a
Dividend40.00 (3.87%)
Ex-Dividend DateApr 18, 2025
Volume3,254
Average Volume32,285
Open1,029.90
Previous Close1,026.88
Day's Range1,011.00 - 1,036.33
52-Week Range793.00 - 1,241.00
Beta-0.03
RSI49.31
Earnings DateMar 26, 2026

About Highnoon Laboratories

Highnoon Laboratories Limited, together with its subsidiaries, manufactures, imports, sells, exports, and markets pharmaceutical and allied consumer products. It offers products in various therapeutic areas, including allergy, anti-infective, cardiology, gastroenterology, metabolic, musculoskeletal, obstetrics and gynaecology, paediatrics, allergy, respiratory, and urology; and generic products under various brands. The company operates in Pakistan, Afghanistan, the United Arab Emirates, France, Kenya, Iraq, Cambodia, Tanzania, Dubai, Sudan, an... [Read more]

Industry Pharmaceuticals
Sector Healthcare
Founded 1984
Employees 2,376
Stock Exchange Pakistan Stock Exchange
Ticker Symbol HINOON
Full Company Profile

Financial Performance

In 2024, Highnoon Laboratories's revenue was 24.63 billion, an increase of 24.60% compared to the previous year's 19.77 billion. Earnings were 3.39 billion, an increase of 38.44%.

Financial Statements